Bradnova O, Kyrou I, Hainer V, Vcelak J, Halkova T, Sramkova P, et al
When available, patients may also have access to manufacturer support resources such as NovoCare and LillyDirect
As a GLP-1 receptor agonist , it helps lower blood sugar, slows digestion, and may lead to significant weight loss in many patients
These consultations may be conducted face-to-face or via telemedicine platforms
The medication is initiated at a low dose (0.25 mg) and gradually increased over 16 weeks to the maintenance dose of 2.4 mg to minimise gastrointestinal side effects, which are common during the early stages of treatment
The body gets used to these changes, letting systems adjust piece by piece instead of all at once